Cystic Fibrosis: Drugs
Commons · Question 109998 · Tabled 2 Feb 2026 · Department of Health and Social Care · Official record
Answered 9 Feb 2026
Question
Asked by Jim Shannon
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that people with cystic fibrosis have access to Orkambi, Symkevi and Kaftrio on the NHS.
Answer
Answered by Zubir Ahmed, 9 Feb 2026
In July 2024, National Institute for Health and Care Excellence (NICE) approved three disease modifying treatments, Orkambi, Symkevi, and Kaftrio, as treatment options for eligible National Health Service patients with cystic fibrosis, under the terms of ...